Nuwellis Past Earnings Performance

Past criteria checks 0/6

Nuwellis has been growing earnings at an average annual rate of 1.9%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9% per year.

Key information

1.9%

Earnings growth rate

84.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.0%
Return on equityn/a
Net Margin-253.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nuwellis makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:22S Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 249-23154
31 Mar 249-20165
31 Dec 239-23175
30 Sep 239-17185
30 Jun 238-17195
31 Mar 238-17195
31 Dec 229-15184
30 Sep 228-17174
30 Jun 228-18175
31 Mar 228-19185
31 Dec 218-20195
30 Sep 218-18195
30 Jun 218-17194
31 Mar 218-17184
31 Dec 207-18174
30 Sep 207-19174
30 Jun 206-19174
31 Mar 206-20174
31 Dec 196-23165
30 Sep 196-22165
30 Jun 196-22165
31 Mar 195-22154
31 Dec 185-17153
30 Sep 184-29143
30 Jun 184-27132
31 Mar 184-27122
31 Dec 174-25101
30 Sep 173-14102
30 Jun 173-1593
31 Mar 172-1685
31 Dec 161-1878
30 Sep 161-19712
30 Jun 160-22715
31 Mar 160-24816
31 Dec 150-27818
30 Sep 150-27918
30 Jun 150-26917
31 Mar 150-26918
31 Dec 140-26917
30 Sep 140-261016
30 Jun 140-261016
31 Mar 140-241015
31 Dec 130-22914
30 Sep 130-19812

Quality Earnings: 22S is currently unprofitable.

Growing Profit Margin: 22S is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 22S is unprofitable, but has reduced losses over the past 5 years at a rate of 1.9% per year.

Accelerating Growth: Unable to compare 22S's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 22S is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: 22S's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies